Table of Contents
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Neuropathic Pain (Neuralgia) 33
Oct 15, 2019: Aptinyx to present preclinical data on NYX-2925 at the 49th Annual Meeting of the Society for Neuroscience 33
Clinical Trial Profile Snapshots 34
Appendix 1939
Abbreviations 1939
Definitions 1939
Research Methodology 1940
Secondary Research 1940
About GlobalData 1941
Contact Us 1941
Source 1942
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Region, 2019* 7
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Neuropathic Pain (Neuralgia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Neuropathic Pain (Neuralgia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Neuropathic Pain (Neuralgia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Neuropathic Pain (Neuralgia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Phase, 2019* 23
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Neuropathic Pain (Neuralgia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
List of Figures
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 16
Neuropathic Pain (Neuralgia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Neuropathic Pain (Neuralgia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Neuropathic Pain (Neuralgia) to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 19
Neuropathic Pain (Neuralgia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Neuropathic Pain (Neuralgia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
Neuropathic Pain (Neuralgia) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Neuropathic Pain (Neuralgia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Neuropathic Pain (Neuralgia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
GlobalData Methodology 1940
【免責事項】
https://www.marketreport.jp/reports-disclaimer